hsa-miR-21

ncRNA information

ncRNA name

hsa-miR-21

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PDCD4

Cancer information

Cancer name

Esophageal Cancer

Cancer site

Esophagus

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-21 affects the sensitivity of esophageal cancer to cisplatin through targeting PDCD4.

Tissue resource

human esophageal cancer cell lines TE-1

human esophageal cancer cell lines Eca109/DDP

human normal esophageal cell lines Het-1A

Experiment

Dual-luciferase reporter assay


Institute

American Type Culture Collection

Country

USA

Continent

North American